TaiMed

Asia Map

Asia

FiercePharmaAsia—Merck-Eisai, JW Therapeutics, novel HIV med

Merck gets half of Lenvima's sales in $5.8 billion deal; Juno and WuXi's CAR-T JV got $90 million; FDA approved Taiwanese firm's HIV drug.

Angus Liu Mar 9, 2018 10:01am

WuXi Biologics plant

New med being produced at first FDA-OK’d China biologics plant

Mar 8, 2018 10:20am

Electromicrograph showing an HIV-infected T cell in blue and yellow

FDA approves Taiwanese firm’s Trogarzo for drug-resistant HIV

Mar 7, 2018 8:55am